LifeMD, Inc. (LFMD) director Roberto Simon receives multiple restricted stock grants

Rhea-AI Filing Summary

Simon Roberto reported acquisition or exercise transactions in this Form 4 filing.

LifeMD, Inc. director Roberto Simon reported three equity compensation awards of common stock on December 2, 2024. These were grants of restricted shares totaling 50,000; 6,162; and 24,648 shares at a stated price of $0.0000 per share. One grant vests on December 2, 2024, one vests immediately, and one vests on June 1, 2025.

Insider Trade Summary

Net Buyer: 80,810 shares

Net Buy 3 txns

Insider Simon Roberto

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	50,000	$0.00	$0.00
Grant/Award	Common Stock F2	6,162	$0.00	$0.00
Grant/Award	Common Stock F3	24,648	$0.00	$0.00

Holdings After Transaction: Common Stock — 180,810 shares (Direct)

Footnotes (3)

1. F1. The grant of restricted shares vests on December 2, 2024.
2. F2. The grant of restricted shares vests immediately.
3. F3. The grant of restricted shares vests on June 1, 2025.

Key Figures

Restricted share grant 1: 50,000 shares Restricted share grant 2: 6,162 shares Restricted share grant 3: 24,648 shares

3 metrics

Restricted share grant 1 50,000 shares Restricted common stock; vests on December 2, 2024; price $0.0000 per share

Restricted share grant 2 6,162 shares Restricted common stock; vests immediately; price $0.0000 per share

Restricted share grant 3 24,648 shares Restricted common stock; vests on June 1, 2025; price $0.0000 per share

Key Terms

restricted shares, grant, award, or other acquisition, direct ownership

3 terms

restricted shares financial

"The grant of restricted shares vests on December 2, 2024."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

grant, award, or other acquisition regulatory

"transaction_code_description: Grant, award, or other acquisition"

direct ownership financial

"All three transactions are classified with ownership_type direct"

FAQ

What equity awards did LifeMD (LFMD) director Roberto Simon receive on December 2, 2024?

Roberto Simon received three grants of restricted common stock totaling 50,000; 6,162; and 24,648 shares. All awards were reported at a stated price of $0.0000 per share as director compensation.

When do Roberto Simon’s new LifeMD (LFMD) restricted share grants vest?

One grant of 50,000 restricted shares vests on December 2, 2024, another grant of 6,162 restricted shares vests immediately, and a third grant of 24,648 restricted shares vests on June 1, 2025.

Were Roberto Simon’s LifeMD (LFMD) stock awards reported as purchases or grants?

They were reported as grant, award, or other acquisition transactions under code “A,” indicating equity compensation awards rather than open-market purchases or sales. All are classified as direct ownership of common stock.

Did the LifeMD (LFMD) Form 4/A show any stock sales by Roberto Simon?

No. The filing reports three acquisition transactions of restricted common stock and no sales or dispositions. The transaction summary shows acquireCount of three and sellCount of zero.

Are Roberto Simon’s LifeMD (LFMD) restricted share grants subject to vesting conditions?

Yes. Footnotes state that 50,000 shares vest on December 2, 2024, 6,162 shares vest immediately, and 24,648 shares vest on June 1, 2025, reflecting time-based vesting conditions on these awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 06:07 PM Accepted by SEC EDGAR 08/13/2026 - 06:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simon Roberto

(Last) (First) (Middle)

C/O LIFEMD, INC.

236 FIFTH AVENUE, 4TH FLOOR

(Street)

NEW YORK NEW YORK 10001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeMD, Inc. [ LFMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
12/02/2024

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
12/05/2024

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/02/2024		A		50,000(1)	A	$0	150,000	D
Common Stock	12/02/2024		A		6,162(2)	A	$0	156,162	D
Common Stock	12/02/2024		A		24,648(3)	A	$0	180,810	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The grant of restricted shares vests on December 2, 2024.

2. The grant of restricted shares vests immediately.

3. The grant of restricted shares vests on June 1, 2025.

	/s/ Roberto Simon	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)